|
|
|
| . |
|
The lifeblood of a business Sweden-based Gambro has had tremendous success in delivering the best in blood and cell-related products and services in over 90 countries. Driving forward one of the world’s leading companies in the production of dialysis products, operation of dialysis clinics and delivering blood bank technology, Sören Mellstig is leading Gambro along a precise business path. “My vision is to see to it that Gambro is a leading company wherever we compete,” says Mellstig, Gambro’s CEO. “To do this we should have global processes implemented on a local level faster and more efficiently than anyone else in the industry. That will give us the kind of momentum in creating cash flow, growth and profitability that creates a barrier to the competition.” And performing and succeeding is exactly what Gambro has done. With over 21,000 employees in 40 countries and sales activities in an additional 50, Gambro has been able to maximize the benefits of its advanced technologies and expertise in its health-care niche to become a global leader. In its efforts to streamline and advance the dialysis process, which dates back to the invention of the first plate dialyzer by Professor Nils Alwell in Sweden in 1963, Gambro has obtained more than 700 patents in the last ten years. At the same time, Gambro has established more than 700 dialysis clinics worldwide serving more than 54,000 patients. It has increased its presence in Japan and the rest of Asia, where patients and the health care industry in this burgeoning market increasingly demand better technology and more cost-effective solutions.
|
 |
